These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cell-based Tolerogenic Therapy, Experience from Animal Models of Multiple Sclerosis, Type 1 Diabetes and Rheumatoid Arthritis. Stojanovic I; Dimitrijevic M; Vives-Pi M; Mansilla MJ; Pujol-Autonell I; Rodríguez-Fernandez S; Palova-Jelínkova L; Funda DP; Gruden-Movsesijan A; Sofronic-Milosavljevic L; Hilkens CMU; Martinez-Caceres E; Miljkovic D Curr Pharm Des; 2017; 23(18):2623-2643. PubMed ID: 28201972 [TBL] [Abstract][Full Text] [Related]
3. Progress toward production of immunologic tolerance with no or minimal toxic immunosuppression for prevention of immunodeficiency and autoimmune diseases. Good RA World J Surg; 2000 Jul; 24(7):797-810. PubMed ID: 10833246 [TBL] [Abstract][Full Text] [Related]
4. Neuropeptides as therapeutic approach to autoimmune diseases. Gonzalez-Rey E; Delgado-Maroto V; Souza Moreira L; Delgado M Curr Pharm Des; 2010; 16(28):3158-72. PubMed ID: 20687881 [TBL] [Abstract][Full Text] [Related]
5. Tolerogenic antibodies and fusion proteins to prevent graft rejection and treat autoimmunity. Chatenoud L Mol Med Today; 1998 Jan; 4(1):25-30. PubMed ID: 9494967 [TBL] [Abstract][Full Text] [Related]
6. Progress towards the clinical use of CD3 monoclonal antibodies in the treatment of autoimmunity. Chatenoud L Curr Opin Organ Transplant; 2009 Aug; 14(4):351-6. PubMed ID: 19610168 [TBL] [Abstract][Full Text] [Related]
7. Regulatory immune cells and functions in autoimmunity and transplantation immunology. Papp G; Boros P; Nakken B; Szodoray P; Zeher M Autoimmun Rev; 2017 May; 16(5):435-444. PubMed ID: 28286106 [TBL] [Abstract][Full Text] [Related]
8. Effects of immunomodulators on the response induced by vaccines against autoimmune diseases. Marciani DJ Autoimmunity; 2017 Nov; 50(7):393-402. PubMed ID: 28906131 [TBL] [Abstract][Full Text] [Related]
16. Tolerizing Strategies for the Treatment of Autoimmune Diseases: From Cauwels A; Tavernier J Front Immunol; 2020; 11():674. PubMed ID: 32477325 [TBL] [Abstract][Full Text] [Related]
17. Induction of tolerogenic dendritic cells by NF-κB blockade and Fcγ receptor modulation. Carreño LJ; Riedel CA; Kalergis AM Methods Mol Biol; 2011; 677():339-53. PubMed ID: 20941620 [TBL] [Abstract][Full Text] [Related]
18. Tolerogenic dendritic cells for autoimmune disease and transplantation. Thomson AW; Robbins PD Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii90-6. PubMed ID: 19022823 [TBL] [Abstract][Full Text] [Related]
19. Checkpoints in lymphocyte development and autoimmune disease. von Boehmer H; Melchers F Nat Immunol; 2010 Jan; 11(1):14-20. PubMed ID: 20016505 [TBL] [Abstract][Full Text] [Related]